Inflammatory bowel diseases, (IBD) including Crohn's disease and ulcer
ative colitis, are chronic systemic disorders associated with intestin
al and other systemic features. Common hematological manifestations of
IBD include: anemia, hypercoagulable state, leukocytosis and thromboc
ytosis. Recently it has been recognized that lymphoma and leukemia can
also be associated with both Crohn's disease and ulcerative colitis.
Careful review of the literature reveals more than 30 cases of leukemi
a reported in patients with IBD. Epidemiological data show that this a
ssociation is statistically significant (relative risk of 5.3; p < 0.0
1; 95% confidence interval). This review attempts to characterize the
clinical features of this association. The etiology of leukemia in the
se cases seems to be multifactorial and may involve: genetic susceptib
ility, environmental factors, immune abnormalities, prior exposure to
diagnostic radiation and a variety of therapeutic modalities. No defin
itive time interval, specific pattern or correlation between the exten
t of bowel involvement and type of leukemia was found. Treatment of le
ukemia might affect the activity and severity of the inflammatory bowe
l disease, but there is very little data relating to this issue. There
is some evidence suggesting that bone marrow transplantation performe
d for leukemia may induce remission of both diseases. Further investig
ation is still required in the future in order to establish a definite
relationship between these two disorders.